top of page
internal journal of oncology
Combined effect of green tea and Ganoderma lucidum on invasive behavior of breast cancer cells
internal journal of oncology
Reishimax
product information page
abstract studies
25 separate studies referenced
KEY INGREDIENTS
Red Reishi Mushroom Extract (Ganoderma Lucidum)
Standardized to 6% triterpenes and 13.5% polysaccharides, for consistent, effective immune support benefits.*
ALL INGREDIENTS
Reishi Mushroom (Ganoderma lucidum) Powdered Extract (12:1) with Spores 500 mg
OTHER INGREDIENTS
Gelatin, Stearic Acid
Results
Journal of cancer integrative medicine
Inhibition of colorectal cancer
University of Louisville
Ganoderma luciduminhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-κκB signaling
*This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
products based on science not marketing
We have developed our own standards for our development and manufacturing processes—we maintain quality, efficacy, and safety controls through each and every stage to ensure unsurpassed results that meet only the highest standards and comply with all relevant government requirements. The key to this consistent quality in our products is what we call our 6S Quality Process. This process involves a set of rigorous, highly integrated activities and includes multiple layers of scientific testing and attention to detail. It requires consistent collaboration and a unified commitment to quality.
Pharmanex selects what we believe are the safest compounds and highest quality ingredients to incorporate into our formulations. We set specifications to provide a basis for active compounds, ingredients, and criteria for finished products. These criteria help establish ingredient standards, and provide specific characteristics to guide consistent manufacturing. Where appropriate, Pharmanex products are carefully analyzed to not only identify the active components, but to ensure consistent manufacturing and product quality.
Once a raw material selection is made, Pharmanex scientists investigate potential commercial sources that can guarantee availability, quality, and concentration of key ingredient components. Pharmanex evaluates these raw material sources to ensure quality and suitability for product formulation, and monitors active ingredient concentration when applicable.
In order to be considered for use in Pharmanex products, materials must pass criteria for effectiveness, suitability for formulation, and consumer safety. Pharmanex works with experts and raw material suppliers around the world to gather both historical and new scientific insights about the unique ingredients within our products.
Pharmanex raw materials must meet our specifications to certify their readiness for product manufacturing. When there are wide variations in active components of a natural or botanical ingredient, we select only those materials that provide the specified amount of these active constituents. Furthermore, our scientists strive to formulate products to contain ingredients at the concentration or strength shown to be efficacious. Once manufactured, Pharmanex products are tested to meet their finished good specifications before they leave the manufacturer.
Pharmanex adheres to high product safety standards by reviewing scientific literature and conducting standard safety studies. Pharmanex conducts standard tests specific to nutrition and personal care products respectively. Examples of safety testing include testing for the presence of microbes, heavy metals, and other contaminants and determination of irritation and/or allergic reactions. Often, we confirm safety and validate our conclusions by using external testing groups.
Pharmanex scientific literature and/or research studies. For key products, we conduct documented clinical studies to determine product and ingredient efficacy and support product and ingredient claims
bottom of page